Status:
COMPLETED
Development of Magnetic Resonance Spectroscopy (MRS) Biomarkers of Tumor Metabolism (MK-0000-145)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Glioma
Eligibility:
All Genders
18-70 years
Brief Summary
This study will evaluate the test-retest repeatability of lactate and other metabolites measured by single voxel magnetic resonance spectroscopy (MRS) and multi-voxel magnetic resonance spectroscopic ...
Eligibility Criteria
Inclusion
- Male and female patients aged 18-70 years old with newly diagnosed operable glioma of grade II or higher which is \> 3cm in diameter based on radiographic examination
- Patients about to receive biopsy or resection of newly diagnosed glioma
Exclusion
- Contraindication to magnetic resonance imaging (MRI): e.g. cardiac pacemaker, metallic implants, known contrast allergy, and pregnancy
- Impaired renal function
- Current or previous chemotherapy, radiation, or other tumor treatment excluding steroids
- Tumor location extra-cerebral, temporal, or in close proximity to frontal sinus
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT01138813
Start Date
March 1 2009
End Date
February 1 2010
Last Update
October 12 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.